Skip to Content
Jump to the top of the page

William Blair Thinking

  • Why the Youth Enrichment Services Market Is Growing (and Recession Resilient)

    As parents increasingly look to provide their kids with an edge, the youth enrichment sector is booming—and emerging as a highly compelling investment category.

    Read more
  • Biotech Breakthroughs: Gene Editing Moves Beyond the Hype

    In this episode of Biotech Breakthroughs, Matt Phipps, Ph.D., group head of biotech research, and William Blair biotech analyst Myles Minter, Ph.D., discuss lessons from the first approved ex‑vivo product and highlight key 2026 catalysts across CRISPR, base editing, RNA editing, and DNA writing.

    Listen to the podcast
  • How Disruption in the Strait of Hormuz Can Move Markets Fast

    The Strait of Hormuz is more than an oil chokepoint—disruptions can ripple through energy markets, food inputs, and critical materials worldwide.

    Read more

Our Mission, Vision, and Values

At William Blair, we're committed to our colleagues, our clients, and our communities. Serving our clients starts with the capabilities and collaboration of our team—making our employees our most important asset. When we create an environment where employees perform their best, our delivery for clients will be the best it can be.

Learn more about our mission, vision, and values

Global Community Partners

We are proud of our signature Global Community Partners program, through which employees nominate organizations to receive catalytic financial support and significant volunteerism opportunities every two years.

More about our community partners

Our Latest News

  • Broadtree Partners Raises Multi-Asset Continuation Fund

    William Blair acted as exclusive financial advisor to Broadtree Partners, LLC in connection with its successful closing of a multi-asset continuation fund with approximately $240 million of total commitments.

    Read more
  • Aktis Oncology, Inc.: Initiation of Research Coverage

    William Blair initiated research coverage of Aktis Oncology, Inc. (AKTS $18.60), a clinical-stage radiopharmaceuticals company that is focused on the actinium-225 payload.

    Read more
  • William Blair Initiates Coverage of Three Largest Healthcare Distributors

    William Blair initiated research coverage of McKesson Corporation (MCK $828.11), Cencora, Inc. (COR $308.19), and Cardinal Health, Inc. (CAH $199.85), the three largest healthcare distributors.

    Read more

Join Our Team

Finding, attracting, and developing talented people is the foundation of our success. Learn about the promising career opportunities currently available at William Blair.

Search our job openings
Women sitting outside with a laptop

Delivered to Your Inbox

Stay up-to-date with the latest William Blair news and insights

Are you sure you want to leave?

Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.

For disclosure information, please visit www.williamblair.com/disclosures